Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Amortization - Intangibles (2016 - 2018)

Historic Amortization - Intangibles for Ironwood Pharmaceuticals (IRWD) over the last 3 years, with Q3 2018 value amounting to $1.2 million.

  • Ironwood Pharmaceuticals' Amortization - Intangibles fell 3890.35% to $1.2 million in Q3 2018 from the same period last year, while for Dec 2018 it was $8.1 million, marking a year-over-year increase of 3052.78%. This contributed to the annual value of $8.1 million for FY2018, which is 3052.78% up from last year.
  • Ironwood Pharmaceuticals' Amortization - Intangibles amounted to $1.2 million in Q3 2018, which was down 3890.35% from $3.5 million recorded in Q2 2018.
  • Ironwood Pharmaceuticals' Amortization - Intangibles' 5-year high stood at $3.5 million during Q4 2017, with a 5-year trough of $420000.0 in Q1 2017.
  • For the 3-year period, Ironwood Pharmaceuticals' Amortization - Intangibles averaged around $2.2 million, with its median value being $2.5 million (2016).
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Amortization - Intangibles crashed by 6046.95% in 2017, and later soared by 72761.9% in 2018.
  • Ironwood Pharmaceuticals' Amortization - Intangibles (Quarter) stood at $3.3 million in 2016, then increased by 5.33% to $3.5 million in 2017, then tumbled by 66.66% to $1.2 million in 2018.
  • Its last three reported values are $1.2 million in Q3 2018, $3.5 million for Q2 2018, and $3.5 million during Q1 2018.